Journal of Neurochemistry

Article	Citations
Microglial phagocytosis of neurons in neurodegeneration, and its regulation	144
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease	111
Chrono‐nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns	110
Exosomes in Parkinson disease	83
Microbiota‐gut‐brain axis as a regulator of reward processes	75
Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease	64
Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer	56
The role of neuroimaging in Parkinson’s disease	54
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance	54
Emerging role of PARP‐1 and PARthanatos in ischemic stroke	50
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD	48
Iron, ferroptosis, and ischemic stroke	44
Ferroptosis: An emerging therapeutic target in stroke	43
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species	42
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)	42
Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex	41
Amyloid processing in COVID‐19‐associated neurological syndromes	39
The multi‐functional RNA‐binding protein G3BP1 and its potential implication in neurodegenerative disease	39
24S‐hydroxycholesterol: Cellular effects and variations in brain diseases	38
Synaptophysin‐dependent synaptobrevin‐2 trafficking at the presynapse‐Mechanism and function	38
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+	38
Regulators of cholinergic signaling in disorders of the central nervous system	38
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease	37
Circuit selectivity in drug versus natural reward seeking behaviors	36
Toll‐like receptor 2 activation and up‐regulation by high mobility group box‐1 contribute to post‐operative neuroinflammation and cognitive dysfunction in mice	36

Hippocampal hyperactivity in a rat model of Alzheimer’s disease	36
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids	35
Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes	35
Addiction‐related neuroadaptations following chronic nicotine exposure	35
Microglia‐dependent remodeling of neuronal circuits	34
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders	34
Glucocorticoid‐mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis	32
Neuromuscular junction‐on‐a‐chip: ALS disease modeling and read‐out development in microfluidic devices	32
Neurobiology of alcohol seeking behavior	31
STING mediates neuroinflammatory response by activating NLRP3‐related pyroptosis in severe traumatic brain injury	30
DJ‐1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons	30
Advances in understanding meso‐cortico‐limbic‐striatal systems mediating risky reward seeking	30
Ponesimod protects against neuronal death by suppressing the activation of A1 astrocytes in early brain injury after experimental subarachnoid hemorrhage	29
Molecular insights into psychedelic drug action	29
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings	29
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing	29
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation	29
Inhibiting Brd4 alleviated PTSD‐like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats	28
Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets	28
Erythropoietin and derivatives: Potential beneficial effects on the brain	28
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine	28
A balancing act: the role of pro‐ and anti‐stress peptides within the central amygdala in anxiety and alcohol use disorders	27
Sex‐specific alterations in NAD+ metabolism in 3xTg Alzheimer’s disease mouse brain assessed by quantitative targeted LC‐MS	27
It’s more than just interoception: The insular cortex involvement in alcohol use disorder	26
The axonal endolysosomal and autophagic systems	26
The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration	25
Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice	25
Role of Ten eleven translocation‐2 (Tet2) in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease	25
MECP2 and the biology of MECP2 duplication syndrome	24
A multi‐level assessment of the bidirectional relationship between aging and the circadian clock	23
Regional and sex differences in spontaneous striatal dopamine transmission	23
Progranulin in neurodegenerative dementia	23
Transcriptomic, peptidomic, and mass spectrometry imaging analysis of the brain in the ant Cataglyphis nodus	22
Central sympathetic nerve activation in subarachnoid hemorrhage	22
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies	22
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo	22
MicroRNAs in oligodendrocyte development and remyelination	21
Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse	21
Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder	21
Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging	21
Investigating the molecular mechanisms of learning and memory using Caenorhabditis elegans	21
The neurochemistry of social reward during development: What have we learned from rodent models?	21
The 2022 Lady Estelle Wolfson lectureship on neurofilaments	21
Criss‐crossing autism spectrum disorder and adult neurogenesis	20
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis	20
An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington’s disease caudate nucleus	20
A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation	20
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease	20
The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view	20
Orexins (hypocretins): The intersection between homeostatic and hedonic feeding	20

Fluid metabolic pathways after subarachnoid hemorrhage	19
Variability of mitochondrial energy balance across brain regions	19
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis	19
Wolfberry‐derived zeaxanthin dipalmitate delays retinal degeneration in a mouse model of retinitis pigmentosa through modulating STAT3, CCL2 and MAPK pathways	19
LRRK2 at the pre‐synaptic site: A 16‐years perspective	19
Artemisinin inhibits TLR4 signaling by targeting co‐receptor MD2 in microglial BV‐2 cells and prevents lipopolysaccharide‐induced blood–brain barrier leakage in mice	19
MEC17‐induced α‐tubulin acetylation restores mitochondrial transport function and alleviates axonal injury after intracerebral hemorrhage in mice	19
A neurobiological perspective on social influence: Serotonin and social adaptation	19
Psychedelic‐inspired approaches for treating neurodegenerative disorders	19
Is there a role for the p75 neurotrophin receptor in mediating degeneration during oxidative stress and after hypoxia?	18
The penalty of stress ‐ Epichaperomes negatively reshaping the brain in neurodegenerative disorders	18
Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis	18
CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer’s disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion	18
Molecular targets of psychedelic‐induced plasticity	17
A ketogenic diet differentially affects neuron and astrocyte transcription	17
The finger loop as an activation sensor in arrestin	17
Pridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptor	17
Hericerin derivatives activates a pan‐neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory	17
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR	17
Missense mutations in CASK, coding for the calcium‐/calmodulin‐dependent serine protein kinase, interfere with neurexin binding and neurexin‐induced oligomerization	17
Vitamin D: A potent regulator of dopaminergic neuron differentiation and function	17
Brain energy metabolism: A roadmap for future research	17
Zinc induces reactive astrogliosis through ERK‐dependent activation of Stat3 and promotes synaptic degeneration	17
Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking	16
Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease	16
Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy	16
MicroRNA‐124‐3p attenuates the development of nerve injury–induced neuropathic pain by targeting early growth response 1 in the dorsal root ganglia and spinal dorsal horn	16
Extracellular ATP and cAMP signaling promote Piezo2‐dependent mechanical allodynia after trigeminal nerve compression injury	16
A multi‐omic analysis of the dorsal striatum in an animal model of divergent genetic risk for alcohol use disorder	16
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies	16
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils	16
Sleep and memory: The impact of sleep deprivation on transcription, translational control, and protein synthesis in the brain	15
Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer’s disease	15
Prefrontal cortex miR‐874‐3p prevents lipopolysaccharide‐induced depression‐like behavior through inhibition of indoleamine 2,3‐dioxygenase 1 expression in mice	15
SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration	15
Spinal Nrf2 translocation may inhibit neuronal NF‐κB activation and alleviate allodynia in a rat model of bone cancer pain	15
Contribution of ceramides metabolism in psychiatric disorders	15
Genetically encoded fluorescent sensors for imaging neuronal dynamics in vivo	15
ALS‐linked mutations impair UBQLN2 stress‐induced biomolecular condensate assembly in cells	15
Activation of silent information regulator 1 exerts a neuroprotective effect after intracerebral hemorrhage by deacetylating NF‐κB/p65	15
Serum neurofilament light chain and glial fibrillary acidic protein in AQP4‐IgG‐seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study	15
Aminoacyl‐tRNA synthetases in Charcot–Marie–Tooth disease: A gain or a loss?	15
Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool	14
Neurosteroids: A novel promise for the treatment of stroke and post‐stroke complications	14
Artesunate restores mitochondrial fusion‐fission dynamics and alleviates neuronal injury in Alzheimer's disease models	14
Somatostatin interneurons inhibit excitatory transmission mediated by astrocytic GABAB and presynaptic GABAB and adenosine A1 receptor	14
Human immunodeficiency virus‐1/simian immunodeficiency virus infection induces opening of pannexin‐1 channels resulting in neuronal synaptic compromise: A novel therapeutic opportunity to prevent Neur	14
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders	14
Glucose availability limits microglial nitric oxide production	14
Selective activation and down‐regulation of Trk receptors by neurotrophins in human neurons co‐expressing TrkB and TrkC	14
Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease	14
α‐synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease	14
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease	14
Do glia provide the link between low‐grade systemic inflammation and normal cognitive ageing? A 1H magnetic resonance spectroscopy study at 7 tesla	14
Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget	14
Heterogeneity of ferrous iron‐containing endolysosomes and effects of endolysosome iron on endolysosome numbers, sizes, and localization patterns	14
Trajectory of change in brain complement factors from neonatal to young adult humans	14
A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease	14
Antimicrobial protein REG3A and signaling networks are predictive of stroke outcomes	14
Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids	14
Thioredoxin interacting protein drives astrocytic glucose hypometabolism in corticosterone‐induced depressive state	13
SARS‐CoV‐2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes	13
Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer’s disease model mice	13
The netrin‐1 receptor DCC promotes the survival of a subpopulation of midbrain dopaminergic neurons: Relevance for ageing and Parkinson’s disease	13
Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives	13
A critical update on the leptin‐melanocortin system	13
Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine‐tolerant rats	13
Cortical VIP+/ChAT+ interneurons: From genetics to function	13
Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease‐related changes	13
Heme oxygenase‐1: The roles of both good and evil in neurodegenerative diseases	13
Stop the rot. Enzyme inactivation at brain harvest prevents artifacts	13
Endothelial cell biomarkers in critically ill COVID‐19 patients with encephalitis	13
Hyaluronidase inhibition accelerates functional recovery from stroke in the mouse brain	12
Neurotensin and energy balance	12
Spontaneous, synchronous zinc spikes oscillate with neural excitability and calcium spikes in primary hippocampal neuron culture	12
Expression of glucose transporter‐2 in murine retina: Evidence for glucose transport from horizontal cells to photoreceptor synapses	12
Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ)	12
Bile‐duct ligation renders the brain susceptible to hypotension‐induced neuronal degeneration: Implications of ammonia	12
Mice deficient in the NAAG synthetase II gene Rimkla are impaired in a novel object recognition task	12
Cytisine is neuroprotective in female but not male 6‐hydroxydopamine lesioned parkinsonian mice and acts in combination with 17‐β‐estradiol to inhibit apoptotic endoplasmic reticulum stress in dopamin	12

The role of astrocytes in generating circadian rhythmicity in health and disease	12
Akt3‐mTOR regulates hippocampal neurogenesis in adult mouse	12
Biological and methodological complexities of beta‐amyloid peptide: Implications for Alzheimer’s disease research	12
Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity	12
Diffusion kurtosis imaging detects the time‐dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease	12
The polyphenol EGCG directly targets intracellular amyloid‐β aggregates and promotes their lysosomal degradation	12
Mulberroside A repairs high fructose diet‐induced damage of intestinal epithelial and blood–brain barriers in mice: A potential for preventing hippocampal neuroinflammatory injury	12
Cortical reorganization of the glutamate synapse in the activity‐based anorexia rat model: Impact on cognition	12
Tau in the gut, does it really matter?	12
Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease	11
In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions	11
Palmitate‐mediated induction of neuropeptide Y expression occurs through intracellular metabolites and not direct exposure to proinflammatory cytokines	11
Copper bis(thiosemicarbazone) complexes modulate P‐glycoprotein expression and function in human brain microvascular endothelial cells	11
Cerebrospinal fluid and serum protein markers in autism: A co‐twin study	11
Rifaximin protects against circadian rhythm disruption–induced cognitive impairment through preventing gut barrier damage and neuroinflammation	11
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma	11
Poly (ADP‐ribose) polymerase 1‐mediated defective mitophagy contributes to painful diabetic neuropathy in the db/db model	11
Investigating the NLRP3 inflammasome and its regulator miR‐223‐3p in multiple sclerosis and experimental demyelination	11
Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids	11
Crystal structure of glutamate dehydrogenase 2, a positively selected novel human enzyme involved in brain biology and cancer pathophysiology	11
Mitochondrial sodium/calcium exchanger NCLX regulates glycolysis in astrocytes, impacting on cognitive performance	11
Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport	11
Tardive neurotoxicity of anticholinergic drugs: A review	11
Adult hippocampal neurogenesis and social behavioural deficits in the R451C Neuroligin3 mouse model of autism are reverted by the antidepressant fluoxetine	11
Distinct brain regional proteome changes in the rTg‐DI rat model of cerebral amyloid angiopathy	11
The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease	11
Pigment epithelium‐derived factor (PEDF) and derived peptides promote survival and differentiation of photoreceptors and induce neurite‐outgrowth in amacrine neurons	11
An in vitro model of glucose transporter 1 deficiency syndrome at the blood–brain barrier using induced pluripotent stem cells	11
Neuropeptide CART modulates dopamine turnover in the nucleus accumbens: Insights into the anatomy of rewarding circuits	10
Neurovascular coupling is optimized to compensate for the increase in proton production from nonoxidative glycolysis and glycogenolysis during brain activation and maintain homeostasis of pH, p	10
Schizophrenia risk candidate EGR3 is a novel transcriptional regulator of RELN and regulates neurite outgrowth via the Reelin signal pathway in vitro	10
CDGSH iron sulfur domain 2 over‐expression alleviates neuronal ferroptosis and brain injury by inhibiting lipid peroxidation via AKT/mTOR pathway following intracerebr	10
α2δ‐1 protein promotes synaptic expression of Ca2+ permeable–AMPA receptors by inhibiting GluA1/GluA2 heteromeric assembly in the hypothalamus in hypertensi	10
CRISPR/Cas9‐mediated grna gene knockout leads to neurodevelopmental defects and motor behavior changes in zebrafish	10
Andrographolide restores glucose uptake in rat hippocampal neurons	10
Distinct dose‐dependent effects of methamphetamine on real‐time dopamine transmission in the rat nucleus accumbens and behaviors	10
Targeting focal ischemic and hemorrhagic stroke neuroprotection: Current prospects for local hypothermia	10
Molecular signatures from multi‐omics of autism spectrum disorders and schizophrenia	10
Phosphorylation of Collapsin Response Mediator Protein 1 (CRMP1) at Tyrosine 504 residue regulates Semaphorin 3A‐induced cortical dendritic growth	10
The metabolite p‐cresol impairs dendritic development, synaptogenesis, and synapse function in hippocampal neurons: Implications for autism spectrum disorder	10
Sensitivity of olfactory sensory neurons to food cues is tuned to nutritional states by Neuropeptide Y signaling	10
Loss of MUNC18‐1 leads to retrograde transport defects in neurons	10
Spinal interleukin‐1β induces mechanical spinal hyperexcitability in rats: Interactions and redundancies with TNF and IL‐6	10
Muscarinic signaling regulates voltage‐gated potassium channel KCNQ2 phosphorylation in the nucleus accumbens via protein kinase C for aversive learning	10
The role of the neuronal microenvironment in sensory function and pain pathophysiology	10
Butyrylcholinesterase in lipid metabolism: A new outlook	10
Up‐regulation of miR‐335 and miR‐674‐3p in the rostral ventrolateral medulla contributes to stress‐induced hypertension	10
Tau liquid–liquid phase separation is modulated by the Ca2+‐switched chaperone activity of the S100B protein	10
Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications	10
RNA editing‐mediated regulation of calcium‐dependent activator protein for secretion (CAPS1) localization and its impact on synaptic transmission	10
Inhibiting α1‐adrenergic receptor signaling pathway ameliorates AD‐type pathologies and behavioral deficits in APPswe/PS1 mouse model	10
Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity‐associated—N6‐methyladenosine—acyl‐CoA synthetase long‐chain family member 4 axis	9
Protein arginine methyltransferase 8 modulates mitochondrial bioenergetics and neuroinflammation after hypoxic stress	9
Colony‐stimulating factor‐1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone model	9
Function and regulation of cis P‐tau in the pathogenesis and treatment of conventional and nonconventional tauopathies	9
Elucidating memory in the brain via single‐cell transcriptomics	9
Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease	9
Amyloid pathology and synaptic loss in pathological aging	9
Distinct limbic dopamine regulation across olfactory‐tubercle subregions through integration of in vivo fast‐scan cyclic voltammetry and optogenetics	9
Nicotinamide ameliorates energy deficiency and improves retinal function in Cav‐1‐/‐ mice	9
METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease	9
Cerebrospinal fluid levels of L‐glutamate signal central inflammatory neurodegeneration in multiple sclerosis	9
Flavonoid fisetin reverses impaired hippocampal synaptic plasticity and cognitive function by regulating the function of AMPARs in a male rat model of schizophrenia	9
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains	9
Ying Yang 1 engagement in brain pathology	9
Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study	9
LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons	9
Experimental approaches for altering the expression of Abeta‐degrading enzymes	9
Systematic Review ‐ Neuroprotection of ketosis in acute injury of the mammalian central nervous system: A meta‐analysis	9
Metabolically healthy obesity and lipids may be protective factors for pathological changes of alzheimer’s disease in cognitively normal adults	9
Receptor‐interacting protein 3‐phosphorylated Ca2+/calmodulin‐dependent protein kinase II and mixed lineage kinase domain‐like protein mediate intracerebral hemorrhage‐induced ne	9
LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines	9
Single intracerebroventricular progranulin injection adversely affects the blood–brain barrier in experimental traumatic brain injury	9
Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology	9
Dynamic subcellular localization and transcription activity of the SRF cofactor MKL2 in the striatum are regulated by MAPK	9
Improving neuropathic pain treatment – by rigorous stratification from bench to bedside	9
Ganglioside GD3 is up‐regulated in microglia and regulates phagocytosis following global cerebral ischemia	9
Dopamine and relapse to drug seeking	9
Phosphorylation‐dependent control of Activity‐regulated cytoskeleton‐associated protein (Arc) protein by TNIK	8
Glucocerebrosidase 1 and leucine‐rich repeat kinase 2 in Parkinson disease and interplay between the two genes	8
The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease	8
Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume	8
Serum neurofilament light chain in adult and pediatric patients with myelin oligodendrocyte glycoprotein antibody‐associated disease: Correlation with relapses and seizures	8
The adenosine A2Areceptor alleviates postoperative delirium‐like behaviors by restoring blood cerebrospinal barrier permeability in rats	8
Long‐term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis	8
Phosphatidylinositol‐3 kinase mediates the sweet suppressive effect of leptin in mouse taste cells	8
TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia‐reperfusion injury via TAK1‐JNK/p38 pathway	8
Who's in, who's out? Re‐evaluation of lipid raft residents	8
Neurochemical substrates linked to impulsive and compulsive phenotypes in addiction: A preclinical perspective	8
Circulating metabolites associated with incident myocardial infarction and stroke: A prospective cohort study of 90 438 participants	8
Specific detection and deletion of the sigma‐1 receptor widely expressed in neurons and glial cells in vivo	8
Apolipoprotein E ε4 modulates astrocyte neuronal support functions in the presence of amyloid‐β	8
Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation	8
An altered secretome is an early marker of the pathogenesis of CLN6 Batten disease	8
Phase separation of the mammalian prion protein: Physiological and pathological perspectives	8